DRI Healthcare Trust (DHT-UN) Q1 2026 earnings summary

Executive summary

• Achieved record Q1 total income of $50.6 million, up 15% year-over-year, with 18% royalty income growth and strong operational momentum.

• Adjusted EBITDA reached $52.8 million, reflecting a 90% margin for the quarter, driven by internalization synergies and disciplined expense management.

• Completed significant financing initiatives, including $250 million in senior secured notes and restructuring of $79.7 million in preferred securities for C$108.7 million in convertible debentures.

• Portfolio resilience highlighted by strong performance from EMPAVELI, ORSERDU, XENPOZYME, XOLAIR, and a robust pipeline of over $3 billion in potential opportunities.

• Paid a quarterly cash distribution of $0.11 per unit and reactivated the Normal Course Issuer Bid, repurchasing units under NCIB plans.

Financial highlights

• Total income for Q1 2026 was $50.6 million, a 15% increase year-over-year, with adjusted EBITDA of $52.8 million and a 90% margin.

• Total cash receipts were $58.4 million, with adjusted cash earnings per unit of $0.68 and quarterly distribution of $0.11 per unit.

• Trailing 12-month adjusted EBITDA was $166.1 million with an 86% margin; LTM adjusted cash earnings per unit totaled $2.51.

• Cash and cash equivalents stood at $52.5 million; royalties receivable at $54.3 million; credit facility availability was $502.7 million.

• Comprehensive earnings were $0.5 million, compared to a loss of $1.8 million in the prior year.

Outlook and guidance

• Management expects EBITDA margins to remain in the high 80% to 90% range post-internalization, with some reinvestment expected to slightly lower margins in coming quarters.

• Focus remains on efficient execution, disciplined expense management, and long-term sustainable growth, with emphasis on strengthening asset risk framework.

• No immediate revision to annual guidance, but positive trends in ORSERDU and the broader portfolio are being closely monitored.

• Anticipates a transaction toward the latter half of the year, leveraging increased capital capacity.

• Declared a quarterly distribution of $0.11 per unit for Q2 2026, payable July 20, 2026.